Condition
NASH clinical trials and research
As of November 12, 2026, Find a Trial lists 7 NASH clinical trials that are recruiting, at sites in 13 countries (most in Italy (4), United States (3), Belgium (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 13Countries
Newest NASH clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Non-invasive blood and imaging tests for metabolic liver disease | — | Miami, Florida and 3 other locations | Recruiting | Aug 14, 2025 |
| Digital prevention for liver disease management | — | Rome, Lazio | Recruiting | Mar 17, 2025 |
| Digoxin for NASH with stage 2–3 fibrosis | Phase 2 | New Haven, Connecticut and 1 other locations | Recruiting | Sep 19, 2024 |
| Evaluating the risk of liver cancer in patients with fatty liver disease | — | Milan, Milano | Recruiting | Jul 26, 2024 |
| Very low-calorie ketogenic diet for patients with liver disease | — | Bologna | Recruiting | Mar 13, 2024 |
| Investigating how androgens affect liver health in young women | — | San Francisco, California and 1 other locations | Recruiting | Nov 9, 2023 |
| A registry for studying Non-Alcoholic Fatty Liver Disease in Europe | — | Antwerp and 36 other locations | Recruiting | Jun 22, 2020 |
All recruiting trials (7)
-
Non-invasive blood and imaging tests for metabolic liver disease
This project tests whether blood tests and imaging scans can diagnose and stage metabolic-associated steatohepatitis (MASH) and liver fibrosis in adults with metabolic risk factors.
-
Digital prevention for liver disease management
This study is testing a new way to help people with liver disease by using a mobile app for patients and a dashboard for doctors to see if it improves their care and health outcomes.
-
Digoxin for NASH with stage 2–3 fibrosis
This trial will see if taking once-daily digoxin helps clear NASH and reduce liver scarring in adults with biopsy-confirmed NASH and stage 2–3 fibrosis.
-
Evaluating the risk of liver cancer in patients with fatty liver disease
This study is testing how fatty liver disease might lead to liver cancer by looking at genetic and metabolic factors in patients with this condition.
-
Very low-calorie ketogenic diet for patients with liver disease
This study is testing whether a very low-calorie ketogenic diet can improve liver health and help with weight management in people with liver disease compared to a standard low-calorie Mediterranean diet.
-
Investigating how androgens affect liver health in young women
This study is trying to see how hormones called androgens affect liver health in young women, especially those with polycystic ovary syndrome, by comparing liver disease progression between women with and without this condition.
-
A registry for studying Non-Alcoholic Fatty Liver Disease in Europe
This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.
Related topics
Quick answers
How many NASH clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in Italy (4 trials), United States (3 trials), Belgium (1 trial), Finland (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.